Anavex Life Sciences Corp (AVXL)

[powerwalker]

rx, isn't the most significant part of today's PR is that Anavex is stating that the P2b/3 shows benefits that reduce the impact of dementia. If this weren't true, lawsuits will fly when results are disclosed ... no lawyer worth his/her salt would allow a client to state this, unless it is TRUE!! Clayton Parker would not let this out unless it is TRUE!!

In addition to significant improvement in dementia symptoms, blarcamesine demonstrated a reduction of pathological aggregation of amyloid in early Alzheimer’s disease as well as a reduction of brain volume loss, a well-known marker of neurodegeneration.